Hers vs MangoRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MangoRx beats Hers overall, scoring 7.5/10 vs 7.3/10. Hers is more affordable at $199/mo vs $299/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose MangoRx for needle-phobic users who want oral-only glp-1 tablets from a .
A side-by-side look at Hers and MangoRx to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#34 of 52The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership, alongside their existing compounded semaglutide and new compounded tirzepatide programs.
Visit HersMangoRx
#26 of 52Multi-service telehealth platform offering compounded GLP-1 alongside other health services.
Visit MangoRx| Feature | Hers | MangoRx |
|---|---|---|
| Our Score | 7.3/10 | 7.5/10 |
| Starting Price | $199/mo | $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand | Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company |
| Ranking | #34 | #26 |
| Get started | Visit Hers | Visit MangoRx |
Pros & Cons Compared
Hers
Pros
- +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value
MangoRx
Pros
- +Oral dissolving tablets exclusively, zero injections for any GLP-1 option
- +Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
- +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
- +Free 100% online consultation with no video call required
Cons
- −Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
- −Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
- −Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.
Our Verdict
MangoRx edges out Hers with a score of 7.5/10 vs 7.3/10. If budget is your priority, Hers starts at $199/mo compared to MangoRx's $299/mo. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose MangoRx if you want: needle-phobic users who want oral-only glp-1 tablets from a publicly traded company.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Hers nor MangoRx feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Hers or MangoRx tend to look at next.
- Hers vs Sprout Health$199/mo
- Hers vs Enhance MD$212/mo
- Hers vs MEDVi$179/mo
- MangoRx vs MyStart Health$299/mo
- MangoRx vs Direct Meds GLP-1$297/mo
- MangoRx vs Breeze Meds$199/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.